Business Description
Nirvana Life Sciences Inc
NAICS : 541720
SIC : 3741
ISIN : CA6546522054
Compare
Compare
Traded in other countries / regions
NIRV.X.CanadaNIRVF.USA IPO Date
2024-02-23Description
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -35.2 | |||||
Debt-to-Equity | -0.2 | |||||
Debt-to-EBITDA | -0.43 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 63.2 | |||||
3-Year EPS without NRI Growth Rate | 40 | |||||
3-Year FCF Growth Rate | 52.9 | |||||
3-Year Book Growth Rate | -84.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
12-1 Month Momentum % | -8.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.03 | |||||
Quick Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.5 | |||||
Shareholder Yield % | -88.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -1785.71 | |||||
ROIC % | -296.55 | |||||
3-Year ROIIC % | -333.2 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5 | |||||
PE Ratio without NRI | 5.56 | |||||
PEG Ratio | 3.09 | |||||
EV-to-EBIT | -3.87 | |||||
EV-to-EBITDA | -3.87 | |||||
EV-to-FCF | -1.45 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.73 | |||||
Earnings Yield (Greenblatt) % | -25.84 | |||||
FCF Yield % | -77.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NIRVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nirvana Life Sciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.007 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 10.11 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 0.000151 | ||
| 20-Day SMA ($) | 0.077965 | ||
| 12-1 Month Momentum % | -8.44 | ||
| 52-Week Range ($) | 0.0763 - 0.08333 | ||
| Shares Outstanding (Mil) | 22.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nirvana Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nirvana Life Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2025-03-24 | 0.08 (+0.00%) |
Show
Entries
Nirvana Life Sciences Inc Frequently Asked Questions
What is Nirvana Life Sciences Inc(NIRVF)'s stock price today?
The current price of NIRVF is $0.08. The 52 week high of NIRVF is $0.08 and 52 week low is $0.08.
When is next earnings date of Nirvana Life Sciences Inc(NIRVF)?
The next earnings date of Nirvana Life Sciences Inc(NIRVF) is .
Does Nirvana Life Sciences Inc(NIRVF) pay dividends? If so, how much?
Nirvana Life Sciences Inc(NIRVF) does not pay dividend.
Guru Commentaries on OTCPK:NIRVF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nirvana Life Sciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers